ES2759605T8 - Formulaciones de 2-iminobiotina y usos de las mismas - Google Patents
Formulaciones de 2-iminobiotina y usos de las mismasInfo
- Publication number
- ES2759605T8 ES2759605T8 ES11723744T ES11723744T ES2759605T8 ES 2759605 T8 ES2759605 T8 ES 2759605T8 ES 11723744 T ES11723744 T ES 11723744T ES 11723744 T ES11723744 T ES 11723744T ES 2759605 T8 ES2759605 T8 ES 2759605T8
- Authority
- ES
- Spain
- Prior art keywords
- iminobiotin
- formulations
- iminobiotin formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10163925 | 2010-05-26 | ||
PCT/NL2011/050366 WO2011149349A1 (en) | 2010-05-26 | 2011-05-26 | 2-iminobiotin formulations and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2759605T3 ES2759605T3 (es) | 2020-05-11 |
ES2759605T8 true ES2759605T8 (es) | 2020-05-20 |
Family
ID=42655614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11723744T Active ES2759605T3 (es) | 2010-05-26 | 2011-05-26 | Formulaciones de 2-iminobiotina y usos de las mismas |
Country Status (15)
Country | Link |
---|---|
US (2) | US9023878B2 (es) |
EP (1) | EP2575892B1 (es) |
JP (1) | JP5798621B2 (es) |
KR (1) | KR101805950B1 (es) |
CN (1) | CN103037904B (es) |
AU (1) | AU2011258964B2 (es) |
BR (1) | BR112012030014B1 (es) |
CA (1) | CA2837129C (es) |
ES (1) | ES2759605T3 (es) |
HK (1) | HK1183448A1 (es) |
IL (1) | IL223269A (es) |
MX (1) | MX338405B (es) |
NZ (1) | NZ604498A (es) |
RU (1) | RU2627460C2 (es) |
WO (1) | WO2011149349A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090239942A1 (en) | 2006-09-15 | 2009-09-24 | Cloyd James C | Topiramate Compositions and Methods of Making and Using the Same |
AU2011258964B2 (en) | 2010-05-26 | 2015-04-16 | Neurophyxia B.V. | 2-iminobiotin formulations and uses thereof |
AU2016372396B2 (en) | 2015-12-16 | 2022-04-14 | Neurophyxia B.V. | 2-iminobiotin for use in the treatment of brain cell injury |
US10463699B2 (en) | 2016-04-04 | 2019-11-05 | Omeza LLC | Fish oil topical composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
ATE177078T1 (de) * | 1993-10-21 | 1999-03-15 | Searle & Co | Amidino-derivate als no-synthetase inhibitoren |
RU2230062C2 (ru) | 1999-01-21 | 2004-06-10 | Бристол-Маерс Сквибб Ко. | Комплекс ингибитора ras-фарнезилтрансферазы, композиция ингибитора ras-фарнезилтрансферазы, фармацевтическая композиция |
AU777022B2 (en) * | 2000-03-31 | 2004-09-30 | Neurophyxia B.V. | Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
KR20030041577A (ko) * | 2001-11-20 | 2003-05-27 | 디디에스텍주식회사 | 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물 |
US7319090B2 (en) | 2002-11-27 | 2008-01-15 | University Of North Carolina At Chapel Hill | Methods of treating cerebral ischemia |
WO2007035760A1 (en) * | 2005-09-20 | 2007-03-29 | Board Of Regents, The University Of Texas System | Enhanced solubility of preformed calcium citrate by adding citric acid |
AU2007304588A1 (en) | 2006-10-04 | 2008-04-10 | Neurokey A/S | Use of hypothermia inducing drugs to treat ischemia |
AU2011258964B2 (en) * | 2010-05-26 | 2015-04-16 | Neurophyxia B.V. | 2-iminobiotin formulations and uses thereof |
-
2011
- 2011-05-26 AU AU2011258964A patent/AU2011258964B2/en active Active
- 2011-05-26 CN CN201180034057.8A patent/CN103037904B/zh active Active
- 2011-05-26 US US13/700,090 patent/US9023878B2/en active Active
- 2011-05-26 KR KR1020127033825A patent/KR101805950B1/ko active IP Right Grant
- 2011-05-26 RU RU2013152229A patent/RU2627460C2/ru not_active Application Discontinuation
- 2011-05-26 WO PCT/NL2011/050366 patent/WO2011149349A1/en active Application Filing
- 2011-05-26 MX MX2012013695A patent/MX338405B/es active IP Right Grant
- 2011-05-26 CA CA2837129A patent/CA2837129C/en active Active
- 2011-05-26 ES ES11723744T patent/ES2759605T3/es active Active
- 2011-05-26 EP EP11723744.6A patent/EP2575892B1/en active Active
- 2011-05-26 BR BR112012030014-8A patent/BR112012030014B1/pt active IP Right Grant
- 2011-05-26 JP JP2013512557A patent/JP5798621B2/ja active Active
- 2011-05-26 NZ NZ60449811A patent/NZ604498A/en unknown
-
2012
- 2012-11-26 IL IL223269A patent/IL223269A/en active IP Right Grant
-
2013
- 2013-09-24 HK HK13110904.9A patent/HK1183448A1/xx unknown
-
2015
- 2015-04-01 US US14/676,419 patent/US9616135B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2011258964A1 (en) | 2013-01-17 |
RU2013152229A (ru) | 2015-06-27 |
HK1183448A1 (en) | 2013-12-27 |
IL223269A (en) | 2016-11-30 |
WO2011149349A1 (en) | 2011-12-01 |
CA2837129A1 (en) | 2011-12-01 |
EP2575892B1 (en) | 2019-11-20 |
BR112012030014B1 (pt) | 2021-07-13 |
AU2011258964B2 (en) | 2015-04-16 |
US9023878B2 (en) | 2015-05-05 |
ES2759605T3 (es) | 2020-05-11 |
CN103037904A (zh) | 2013-04-10 |
EP2575892A1 (en) | 2013-04-10 |
JP2013527200A (ja) | 2013-06-27 |
KR20130117659A (ko) | 2013-10-28 |
BR112012030014A2 (pt) | 2016-08-02 |
CA2837129C (en) | 2018-07-03 |
RU2627460C2 (ru) | 2017-08-08 |
US9616135B2 (en) | 2017-04-11 |
MX2012013695A (es) | 2013-02-26 |
KR101805950B1 (ko) | 2017-12-07 |
IL223269A0 (en) | 2013-02-03 |
MX338405B (es) | 2016-04-14 |
NZ604498A (en) | 2014-10-31 |
JP5798621B2 (ja) | 2015-10-21 |
CN103037904B (zh) | 2015-04-22 |
US20150202303A1 (en) | 2015-07-23 |
US20130143936A1 (en) | 2013-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000981A1 (es) | Formulaciones de estrigolactona y sus usos | |
BR112013007499A2 (pt) | piridazinonas - métodos de criação e usos | |
CR20150380A (es) | Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico | |
CO7030961A2 (es) | Benzotienilo-pirrolotriazinas disustituidas y sus usos | |
BR112015006198A2 (pt) | conjunto de cadeira | |
CO6950485A2 (es) | Composiciones perfumantes y usos de las mismas | |
BR112015003838A2 (pt) | formulações de anticorpo e proteína | |
BR112015003125A2 (pt) | ingrediente hidrante cosmético ou7 farmacêutico | |
DK3170508T3 (da) | Vaccineformuleringer | |
CO6950484A2 (es) | Composiciones perfumantes y usos de las mismas | |
IL263978B (en) | Amorphous latrovir and solid pharmaceutical preparations containing it and its uses | |
CO6801713A2 (es) | Heteroarilos y sus usos | |
GT201200303A (es) | Formulaciones farmacéuticas | |
CO6990717A2 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
BR112014009033A2 (pt) | formulações de polímero acrílico | |
CO6870031A2 (es) | Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos | |
BR112013023743A2 (pt) | anticorpo de fator de tecidos humanos e usos do mesmo | |
DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
BR112015007861A2 (pt) | prótese de tecido | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
DK2745849T3 (da) | Polydeoxyribonukleotidsammensætning og anvendelser deraf | |
BR112014005254A2 (pt) | composições antimicrobianas e usos das mesmas | |
CO6801701A2 (es) | Composiciones activas de antitranspirante y fabricación de las mismas | |
CO6862154A2 (es) | Metabolitos de trans-clomifeno y usos de los mismos | |
IT1400392B1 (it) | Dispositivo di protezione delle vertebre cervicali |